A 10-year-old spayed female Domestic Shorthair cat with a...

Thank you for reaching out regarding this geriatric DSH with CKD and neuropathic pain. This is a common scenario, and careful drug selection and dosing are paramount, especially given her renal status.

Gabapentin is an excellent choice for neuropathic pain in cats, but its primary renal excretion necessitates a dose adjustment in patients with compromised kidney function.

Here's my recommendation for an appropriate starting dose and considerations:

Gabapentin Dosing for a Cat with IRIS Stage 2 CKD

Standard Feline Gabapentin Dosing (General Principle):

For chronic pain management in cats without renal impairment, gabapentin is typically dosed at 5-10 mg/kg orally every 8-12 hours, or a fixed dose of 50-100 mg per cat orally every 8-12 hours. For pre-procedural anxiolysis or sedation, higher single doses (e.g., 100-200 mg/cat) are often used.

Consideration for Renal Impairment:

Gabapentin is almost entirely eliminated by the kidneys. Therefore, in a cat with IRIS Stage 2 CKD (Creatinine 2.8 mg/dL, BUN 65 mg/dL), the dosing interval must be extended, or the dose reduced, to prevent accumulation and associated side effects.

Recommended Starting Dose for this Patient:

Given the patient's IRIS Stage 2 CKD and the description of "mild" neuropathic pain, I would recommend starting with a conservative approach:
* 25-50 mg per cat orally, once every 12-24 hours.

I would strongly advise starting at the lower end of this range (e.g., 25 mg per cat orally once every 24 hours) and evaluating the response over 3-5 days. If pain relief is insufficient and side effects are minimal, you can gradually increase to 25 mg BID, then 50 mg once daily, and finally 50 mg BID as tolerated and needed.

Rationale and Important Considerations

* Minimizing Side Effects: The primary side effects of gabapentin are sedation and ataxia. These can be particularly concerning in a CKD patient, as lethargy or decreased appetite could be misinterpreted as worsening renal disease or contribute to dehydration. Starting low and slow allows the patient to acclimate and helps differentiate drug effects from disease progression.
* Titration to Effect: Pain management is highly individualized. The goal is to find the lowest effective dose with the fewest side effects. Careful owner observation of pain signs and adverse effects is crucial for titration.
* Formulation: Gabapentin is available in capsules (100 mg, 300 mg, 400 mg) and an oral solution (250 mg/5 mL). For precise dosing at 25 mg, compounding may be necessary. The oral solution can be difficult to dose accurately for small amounts and often contains xylitol, which is toxic to dogs but generally considered safe for cats in the small amounts found in gabapentin solutions (though caution is always warranted). Confirm the specific formulation with your compounding pharmacy.
* Monitoring:
* Clinical Signs: Monitor closely for sedation, ataxia, changes in appetite, and overall demeanor.
* Pain Assessment: Regularly reassess the cat's pain level using owner reports and any objective measures available.
* Renal Parameters: Continue routine monitoring of renal values as part of her CKD management. While gabapentin itself is not nephrotoxic, its elimination is directly tied to renal function.
* Concurrent Medications: Be mindful of any other medications the cat is receiving, especially those that also cause sedation or are renally excreted.

In summary, for your 10-year-old DSH with IRIS Stage 2 CKD and mild neuropathic pain, an appropriate starting point for gabapentin is 25 mg per cat orally once every 24 hours, with careful titration upwards based on response and tolerance. This methodical approach will allow you to achieve effective pain control while minimizing the risks associated with renal drug accumulation.